Global Polymerase Chain Reaction (PCR) Devices Market Size Study, By Technology (Digital PCR, Real-time PCR), By Product Type (Instrument, Reagent, Consumables, Others), By Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic, Others), By End-User (Hospital, Diagnostic Center, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Academia, Laboratories), and Regional Forecasts 2022–2032
The Global Polymerase Chain Reaction (PCR) Devices Market was valued at approximately USD 13.65 billion in 2023 and is projected to grow at a modest CAGR of 7.0% over the forecast period of 2024–2032. PCR devices, commonly referred to as thermal cyclers, play a critical role in amplifying DNA sequences, supporting their broad application across diverse fields such as clinical diagnostics, oncology, and microbiological research. This growth is further driven by the rising adoption of personalized medicine and precision diagnostics.
Increased utilization in clinical diagnostics and advancements in PCR technologies are fueling market expansion. PCR devices are instrumental in detecting genetic disorders and infectious diseases, ensuring precise diagnosis and treatment. Moreover, the growing reliance on biomarkers for disease diagnosis and the increasing demand for point-of-care diagnostic devices are shaping the market trajectory. Key innovations in real-time and digital PCR technologies have expanded their applications, driving adoption in forensics, pathogen detection, and oncology.
North America currently dominates the market, attributed to favorable government initiatives and established healthcare infrastructure. Meanwhile, the Asia-Pacific region is poised for substantial growth during the forecast period, driven by heightened awareness of early diagnostics and increasing investments in healthcare technologies. Emerging markets in China, India, and Southeast Asia present lucrative opportunities due to their growing patient pool and rising prevalence of chronic diseases.
Major market players included in this report are:• Abbott
• Thermo Fisher Scientific
• BD (Becton, Dickinson and Company)
• bioMérieux
• Danaher
• QIAGEN
• Bio-Rad Laboratories, Inc.
• Siemens Healthineers
• Merck KGaA
• Fluidigm Corporation
• Agilent Technologies, Inc.
• Cytiva
• Stryker Corporation
• Smith+Nephew
• Bruker Corporation
The detailed segments and sub-segments of the market are explained below:By Technology
• Digital PCR
• Real-time PCR
By Product Type
• Instrument
• Reagent
• Consumables
• Others
By Application
• Oncology
• Blood Testing
• Pathogen Detection
• Research
• Forensic
• Others
By End User
• Hospital
• Diagnostic Center
• Pharmaceutical and Biotechnology Companies
• Clinical Research Organizations
• Academia
• Laboratories
________________________________________
By Region:
• North America
U.S.
Canada
Mexico
• Europe
Germany
France
U.K.
Italy
Spain
Turkey
Rest of Europe
• Asia Pacific
China
Japan
India
South Korea
Singapore
Australia
Thailand
Indonesia
Rest of Asia Pacific
• Middle East & Africa
Saudi Arabia
UAE
South Africa
Rest of MEA
• Latin America
Brazil
Argentina
Rest of Latin America
________________________________________
Years considered for the study are as follows:• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways• Market Estimates & Forecast for 10 years from 2022 to 2032
• Annualized revenues and regional-level analysis for each market segment
• Detailed analysis of geographical landscape with country-level insights
• Competitive landscape with information on key players and strategies
• Analysis of key business strategies and recommendations for market entry
• Demand-side and supply-side dynamics analysis of the market
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.